Cytologic screening for cervical cancer, precancerous lesions, atypical cells, and other cytologic abnormalities defined by the Bethesda System.
Test Code
100
Specimen
Gynecological Pap sample collected in ThinPrep® specimen vial
Specimen Requirements
With each specimen, please submit a completed requisition along with pertinent clinical information, e.g., last menstrual period (LMP), hormonal status (postmenopausal, pregnant, postpartum), hormone therapy (including birth control pills, treatment for endocrine responsive malignancy, estrogen creams), use of intrauterine device (IUD), and whether the patient is at high risk for cervical cancer.
Following is a list of risk factors:
Previous gynecological history of dysplasia or cancer